BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26086515)

  • 41. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
    Ruano G; Kost JA
    Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prescription of antidepressants in the treatment of pain: role of pharmacogenetics].
    Rodieux F; Piguet V; Berney P; Desmeules J; Besson M
    Rev Med Suisse; 2015 Jun; 11(480):1374-9. PubMed ID: 26267942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological management of pain in Australian Aged Care Facilities.
    Veal FC; Bereznicki LR; Thompson AJ; Peterson GM
    Age Ageing; 2014 Nov; 43(6):851-6. PubMed ID: 24927723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Managing Pediatric Pain in the Emergency Department.
    Bailey B; Trottier ED
    Paediatr Drugs; 2016 Aug; 18(4):287-301. PubMed ID: 27260499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endpoints in pediatric pain studies.
    van Dijk M; Ceelie I; Tibboel D
    Eur J Clin Pharmacol; 2011 May; 67 Suppl 1(Suppl 1):61-6. PubMed ID: 21107829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Personalized medicine--one size fits one: tailoring pain therapy to individuals' needs.
    Ahmedzai SH
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):83-5. PubMed ID: 23527673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can quantitative sensory testing predict responses to analgesic treatment?
    Grosen K; Fischer IW; Olesen AE; Drewes AM
    Eur J Pain; 2013 Oct; 17(9):1267-80. PubMed ID: 23658120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacogenetics of opioids: a narrative review.
    Kumar S; Kundra P; Ramsamy K; Surendiran A
    Anaesthesia; 2019 Nov; 74(11):1456-1470. PubMed ID: 31454083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetics of pain, opioids, and opioid responsiveness.
    Tremblay J; Hamet P
    Metabolism; 2010 Oct; 59 Suppl 1():S5-8. PubMed ID: 20837195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Managing procedural pain in pediatric patients.
    Cramton RE; Gruchala NE
    Curr Opin Pediatr; 2012 Aug; 24(4):530-8. PubMed ID: 22732639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
    Zaiou M; El Amri H
    Clin Genet; 2017 Mar; 91(3):355-370. PubMed ID: 27714756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Introduction to Personalized Medicine in Pediatrics.
    Bupp CP; English BK; Rajasekaran S; Prokop JW
    Pediatr Ann; 2022 Oct; 51(10):e381-e386. PubMed ID: 36215089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pharmacogenetics of opioid therapy in the management of postpartum pain: a systematic review.
    Baber M; Bapat P; Nichol G; Koren G
    Pharmacogenomics; 2016; 17(1):75-93. PubMed ID: 26652709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. OCT1 pharmacogenetics in pain management: is a clinical application within reach?
    Tzvetkov MV
    Pharmacogenomics; 2017 Nov; 18(16):1515-1523. PubMed ID: 29061087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pediatric Oncology: Managing Pain at the End of Life.
    Snaman JM; Baker JN; Ehrentraut JH; Anghelescu DL
    Paediatr Drugs; 2016 Jun; 18(3):161-80. PubMed ID: 26951239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacology of Common Analgesic and Sedative Drugs Used in the Neonatal Intensive Care Unit.
    Donato J; Rao K; Lewis T
    Clin Perinatol; 2019 Dec; 46(4):673-692. PubMed ID: 31653302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetics and genomics in postoperative pain and analgesia.
    Palada V; Kaunisto MA; Kalso E
    Curr Opin Anaesthesiol; 2018 Oct; 31(5):569-574. PubMed ID: 29994939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
    Solhaug V; Molden E
    Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Assessment of Newly Identified Barriers to and Enablers for Prehospital Pediatric Pain Management.
    Whitley DE; Li T; Jones CMC; Cushman JT; Williams DM; Shah MN
    Pediatr Emerg Care; 2017 Jun; 33(6):381-387. PubMed ID: 26414634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacogenetic Testing for Analgesic Adverse Effects: Pediatric Case Series.
    Manworren RC; Jeffries L; Pantaleao A; Seip R; Zempsky WT; RuaƱo G
    Clin J Pain; 2016 Feb; 32(2):109-15. PubMed ID: 25803758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.